Product Information
CLOMIPHENE CITRATE 50 MG TAB is a generic product labeled by Rising Pharma Holdings Inc., priced at $4.2052 per EA under NDC 64980069003. Its NADAC has been published 72 times since May 21, 2025.
FDA first approved this application on Nov 8, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980069003
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLOMIPHENE CITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA216739FDA Approved
11/8/2024
TE Code
AB
On Market Since
11/19/2024
Pharmacological Classes
Price Statistics
The NADAC for CLOMIPHENE CITRATE 50 MG TAB has been published 72 times since May 21, 2025, and over the history we have for it it has declined 41.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.2052 per EA |
|---|---|
| All-time high | $8.3947 (Jan 14, 2026) |
| All-time low | $4.2052 (Sep 23, 2026) |
| 52-week high | $8.3947 |
| 52-week low | $4.2052 |
| Median price | $7.2110 |
| Average price | $6.7367 |
| Largest weekly change | -12.8% (Feb 18, 2026) |
| Weeks tracked | 72 |
| Tracking since | May 21, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clomiphene Citrtae market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen Agonist/Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOMIPHENE CITRATE 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for CLOMIPHENE CITRATE 50 MG TAB, manufactured by Rising Pharma Holdings Inc., is $4.2052 per EA (NDC 64980069003), effective Sep 30, 2026.
How has the price of CLOMIPHENE CITRATE 50 MG TAB changed over time?
Over the history we have for it, the NADAC for CLOMIPHENE CITRATE 50 MG TAB has declined 41.8%. It has been tracked across 72 weekly CMS publications since May 21, 2025.
What are the highest and lowest recorded NADAC prices for CLOMIPHENE CITRATE 50 MG TAB?
Since May 21, 2025, the NADAC for CLOMIPHENE CITRATE 50 MG TAB has ranged from a low of $4.2052 (Sep 23, 2026) to a high of $8.3947 (Jan 14, 2026), with a median of $7.2110 per EA.
Are there cheaper alternatives to CLOMIPHENE CITRATE 50 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLOMIPHENE CITRATE 50 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOMIPHENE CITRATE 50 MG TAB?
CLOMIPHENE CITRATE 50 MG TAB (NDC 64980069003) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.